trending Market Intelligence /marketintelligence/en/news-insights/trending/18r6hEVaNhfhMlnNQ5WHWA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

India's Torrent Pharmaceuticals recalls hypertension drugs in US, Puerto Rico

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


India's Torrent Pharmaceuticals recalls hypertension drugs in US, Puerto Rico

Torrent Pharmaceuticals Ltd. is voluntarily recalling 73,896 bottles of certain hypertension medications due to high levels of a potentially cancer-causing impurity, the U.S. Food and Drug Administration said.

The regulatory body said the recalls of losartan potassium and hydrochlorothiazide tablets were due to the presence of higher than accepted levels of an impurity called N-methylnitrosobutyric acid.

The action — initiated in the U.S. and Puerto Rico — is classified as a class 2 recall, which, according to the FDA, is a situation in which the use of or exposure to the drug may cause temporary or medically reversible harmful health effects or where the probability of serious adverse health consequences is remote.

Gujarat, India-based Torrent Pharmaceuticals has also twice recalled certain high blood pressure medications for the same reason.